ARCHIVES

FDA Approves Inlyta Pill For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

HHS Agency Says It Has No Jurisdiction And No Cause to Act on I-ELCAP Allegations

March 2, 2012

ORI Progress On Fisher Case Questioned; Panel Not Formed

March 3, 1995

Cancer Letter Editor Wine Reporting Awards

June 11, 1999

Obey Surprises Everyone, Including Himself, And Plugs For More Money For NCI, NHLBI

March 7, 1980

In Radio Address, Clinton Outlines Administration Priorities

October 2, 1998

BRMP Projects Priority Rated

April 11, 1980